 | NDV-HXP-S (known as ButanVac or ADAPTCOV in Brazil, COVIVAC in Vietnam, HXP-GPOVac in Thailand, Patria in Mexico) is a COVID-19 vaccine candidate developed... 14 KB (1,123 words) - 18:34, 9 January 2024 |
 | Retrieved 25 January 2022. "Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand". ClinicalTrials.gov. 21 February 2021. NCT04764422. Retrieved... 98 KB (20,593 words) - 02:58, 8 March 2024 |
(newspaper), a Cuban newspaper Patria, the Mexican name of the NDV-HXP-S Covid-19 vaccine Aurora Pro Patria 1919, an Italian association football club,... 1 KB (224 words) - 19:18, 14 April 2024 |
| its homegrown vaccines amidst criticism, with "ChulaCov19" and set to begin trials in May 2021. Phase I testing of the NDV-HXP-S vaccine began at Mahidol... 28 KB (1,554 words) - 19:45, 23 December 2023 |
its homegrown vaccines amidst criticism, with "ChulaCov19" and set to begin trials in May 2021. Phase I testing of the NDV-HXP-S vaccine began at Mahidol... 172 KB (8,785 words) - 19:22, 19 April 2024 |
The COVID-19 pandemic in Nepal is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2... 181 KB (23,901 words) - 14:23, 6 January 2024 |
 | Jason McLellan (redirect from Jason S. McLellan) as the basis for a new vaccine, NDV-HXP-S, which is undergoing trials in Brazil, Mexico, Thailand and Vietnam. These new vaccines are using a harmless avian... 30 KB (2,822 words) - 17:59, 15 February 2024 |
vector COVID-19 vaccine developed by Institute of Vaccines and Medical Biologicals in Vietnam, later named NDV-HXP-S COVI-VAC (U.S. COVID-19 vaccine), codenamed... 694 bytes (132 words) - 09:19, 30 October 2023 |